“the team are currently refining the grown of the composite skin of the dermis and epidermis, making it more reliable and effective. Their aim is to start clinical trials within approximately 18 months”
So that would be by the end of calendar 2023 or beginning of 2024. Excellent news.
PNV Media Thread, page-2444
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
-0.050(1.98%) |
Mkt cap ! $1.706B | |||
| Open | High | Low | Value | Volume |
| $2.49 | $2.50 | $2.46 | $837.1K | 336.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 59685 | $2.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.47 | 4758 | 10 |
View Market Depth
| Last trade - 13.34pm 04/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |